Advertisement

Obesity Surgery

, Volume 28, Issue 3, pp 850–851 | Cite as

Comparing Apples to Apples. Is it Fair to Compare Suboptimal Doses of Medications to Surgery?

  • Claudia A. Velez-Viveros
  • José G. González-González
  • Marcela Rodríguez-Flores
  • Leonardo G. Mancillas-Adame
Letter to the Editor

Notes

Funding

The authors declare no financial support was received for this communication.

Compliance with Ethical Standards

Conflict of Interest

Claudia Analy Vélez-Viveros has nothing to disclose.

José Gerardo González-González reports personal fees and other from Novo Nordisk, outside the submitted work.

Marcela Rodríguez-Flores reports personal fees from Novo Nordisk, outside the submitted work.

Leonardo Mancillas-Adame reports personal fees from Novo Nordisk, outside the submitted work.

References

  1. 1.
    Bhandari M, Mathur W, Kumar R, et al. Surgical and advanced medical therapy for the treatment of type 2 diabetes in class I obese patients: a short-term outcome. Obes Surg. 2017;27(12):3267–72.  https://doi.org/10.1007/s11695-017-2770-y.CrossRefPubMedGoogle Scholar
  2. 2.
    Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–51.  https://doi.org/10.1056/NEJMoa1600869.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    McCambridge J, Sorhaindo A, Quirk A, et al. Patient preferences and performance bias in a weight loss trial with a usual care arm. Patient Educ Couns. 2014;95(2):243–7.  https://doi.org/10.1016/j.pec.2014.01.003.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Lovshin JA. Glucagon-like Peptide-1 receptor agonists: a class update for treating type 2 diabetes. Can J Diabetes. 2017;41(5):524–35.  https://doi.org/10.1016/j.jcjd.2017.08.242.CrossRefPubMedGoogle Scholar
  5. 5.
    Mancini MC, de Melo ME. The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr. 2017;9(1):44.  https://doi.org/10.1186/s13098-017-0242-0.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Claudia A. Velez-Viveros
    • 1
  • José G. González-González
    • 1
  • Marcela Rodríguez-Flores
    • 2
  • Leonardo G. Mancillas-Adame
    • 1
  1. 1.Endocrinology Division, Internal Medicine DepartmentUniversity Hospital “Dr. José Eleuterio González” and Medical School, Universidad Autónoma de Nuevo LeónMonterreyMexico
  2. 2.Obesity Clinic, Endocrinology and Metabolism DepartmentInstituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”Mexico CityMexico

Personalised recommendations